Emma Gebauer1, Markus A Seeliger1

  • 1Laufer Center for Physical & Quantitative Biology, Department of Pharmacological Sciences, School of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.

Cell chemical biology
|February 16, 2024
PubMed
概括

研究人员确定了Src激酶中的关键突变,这些突变赋予了对ATP竞争性抑制剂的抵抗力. 这种深度突变查揭示了一个动态控制的部位,该部位对于癌症治疗中的耐药性至关重要.